European Archives - Page 176 of 1535 - European Medical Journal

Does Bisoprolol Benefit Patients with COPD? - EMJ

Does Bisoprolol Benefit Patients with COPD?

A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite their high cardiovascular risk.

EAHD web

Hema Now: Behind the Scenes of EAHAD 2026

In this latest episode of Hema Now, we go behind the scenes of the EAHAD 2026 Congress, exploring how the programme is developed, key emerging priorities, and what lies ahead for haemophilia care in Europe.

Global hepatitis elimination profiles reveal policy gaps - EMJ

Global Report Highlights Policy Gaps in Hepatitis Elimination Efforts

A global report shows uneven progress toward WHO hepatitis elimination goals, highlighting persistent policy and implementation gaps in testing and treatment.

EMJ Oncology 14 [Supplement 2] 2026

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

Bimekizumab▼in Hidradenitis Suppurativa (HS)

Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and deep…

30 Jan 2026

Retracted: Putting the Pieces Together: A Patient-Centred Approach to Bronchiectasis Diagnosis

This interactive article has been retracted and a retraction statement has been published.

Recent Developments in NMIBC Research

Globally, there are more than 650,000 newly diagnosed cases of bladder cancer annually, with up to approximately 80% of these cases…

Sustainability

Pharma's 2025 climate report: ambition to execution

As pharma raced to meet climate targets in 2024-2025, it’s proving that scaling medicines doesn’t have to hurt the planet.

Gut Microbiome Predicts Response to Diabetes Drugs

Importantly, baseline gut microbiome profiles predicted changes in glycohaemoglobin among users of both therapies.

Hospital popping out of mobile phone

TrumpRx: Guidance on DTC sales issued to industry

The Office of Inspector General’s bulletin provides a framework for pharma companies selling prescription drugs direct-to-consumers (DTC).